Editorial: Bacteriophages and Their Lytic Enzymes as Alternative Antibacterial Therapies in the Age of Antibiotic Resistance.
作者信息
São-José Carlos, Costa Ana Rita, Melo Luís D R
机构信息
Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal.
Department of Bionanosciences, Kavli Institute of Nanoscience, Delft University of Technology, Delft, Netherlands.
出版信息
Front Microbiol. 2022 Mar 25;13:884176. doi: 10.3389/fmicb.2022.884176. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Bacteriophages and Their Lytic Enzymes as Alternative Antibacterial Therapies in the Age of Antibiotic Resistance.社论：在抗生素耐药时代，噬菌体及其裂解酶作为替代抗菌疗法
Front Microbiol. 2022 Mar 25;13:884176. doi: 10.3389/fmicb.2022.884176. eCollection 2022.
2
Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design.噬菌体编码的细菌细胞壁溶酶及其序列-功能关系在噬菌体衍生产品设计中的意义。
J Virol. 2021 Jun 24;95(14):e0032121. doi: 10.1128/JVI.00321-21.
3
Phages and Enzybiotics in Food Biopreservation.噬菌体和食源生物抗菌肽在食品生物保鲜中的应用
Molecules. 2021 Aug 25;26(17):5138. doi: 10.3390/molecules26175138.
4
Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials.噬菌体衍生裂解酶的工程改造：提高其作为抗菌剂的潜力
Antibiotics (Basel). 2018 Mar 22;7(2):29. doi: 10.3390/antibiotics7020029.
5
Treating bacterial infections with bacteriophages in the 21st century.21世纪利用噬菌体治疗细菌感染
S Afr J Infect Dis. 2022 Mar 29;37(1):346. doi: 10.4102/sajid.v37i1.346. eCollection 2022.
6
Recombinant bacteriophage lysins as antibacterials.重组噬菌体裂解酶作为抗菌剂。
Bioeng Bugs. 2010 Jan-Feb;1(1):9-16. doi: 10.4161/bbug.1.1.9818.
7
Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model.噬菌体裂解酶作为鼠脓毒症模型中耐抗生素肺炎链球菌感染的治疗方法
J Antimicrob Chemother. 2003 Dec;52(6):967-73. doi: 10.1093/jac/dkg485. Epub 2003 Nov 12.
8
Gram-Negative Bacterial Lysins.革兰氏阴性菌溶素
Antibiotics (Basel). 2020 Feb 11;9(2):74. doi: 10.3390/antibiotics9020074.
9
Phage lytic enzymes: a history.噬菌体裂解酶：一段历史。
Virol Sin. 2015 Feb;30(1):26-32. doi: 10.1007/s12250-014-3549-0. Epub 2015 Feb 5.
10
Bacteriophage lytic enzymes: novel anti-infectives.噬菌体裂解酶：新型抗感染药物。
Trends Microbiol. 2005 Oct;13(10):491-6. doi: 10.1016/j.tim.2005.08.007.
引用本文的文献
1
Peri-implant diseases triggered by oral microdysbiosis: pathogenesis and precision intervention strategies.口腔微生态失调引发的种植体周围疾病：发病机制与精准干预策略
Front Microbiol. 2025 Aug 7;16:1639095. doi: 10.3389/fmicb.2025.1639095. eCollection 2025.
2
Efficacy of bacteriophages with Aloe vera extract in formulated cosmetics to combat multidrug-resistant bacteria in skin diseases.含芦荟提取物的噬菌体在配方化妆品中对抗皮肤病多重耐药菌的功效。
Sci Rep. 2025 Feb 5;15(1):4335. doi: 10.1038/s41598-025-86334-y.
3
The potential use of bacteriophages as antibacterial agents in dental infection.噬菌体在口腔感染中作为抗菌剂的潜在用途。
Virol J. 2024 Oct 18;21(1):258. doi: 10.1186/s12985-024-02510-y.
4
Agents Targeting the Bacterial Cell Wall as Tools to Combat Gram-Positive Pathogens.靶向细菌细胞壁的药物：对抗革兰氏阳性病原体的工具。
Molecules. 2024 Aug 27;29(17):4065. doi: 10.3390/molecules29174065.
5
Resistance, Tolerance, Virulence and Bacterial Pathogen Fitness-Current State and Envisioned Solutions for the Near Future.抗性、耐受性、毒力与细菌病原体适应性——当前状况及对近期未来的设想解决方案
Pathogens. 2023 May 22;12(5):746. doi: 10.3390/pathogens12050746.
6
BL02, a phage against carbapenem- and polymyxin-B resistant Klebsiella pneumoniae, isolated from sewage: A preclinical study.BL02，一种针对耐碳青霉烯类和多黏菌素 B 的肺炎克雷伯菌的噬菌体，从污水中分离：一项临床前研究。
Virus Res. 2023 Jul 2;331:199126. doi: 10.1016/j.virusres.2023.199126. Epub 2023 Apr 29.
7
The applications of animal models in phage therapy: An update.动物模型在噬菌体治疗中的应用：最新进展。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2175519. doi: 10.1080/21645515.2023.2175519. Epub 2023 Mar 19.
本文引用的文献
1
Treating Bacterial Infections with Bacteriophage-Based Enzybiotics: In Vitro, In Vivo and Clinical Application.用基于噬菌体的酶生素治疗细菌感染：体外、体内及临床应用
Antibiotics (Basel). 2021 Dec 6;10(12):1497. doi: 10.3390/antibiotics10121497.
2
Phage Therapy for Antibiotic-Resistant Bacterial Infections.噬菌体疗法治疗抗生素耐药性细菌感染
Annu Rev Med. 2022 Jan 27;73:197-211. doi: 10.1146/annurev-med-080219-122208. Epub 2021 Aug 24.
3
Genomic Analysis of a Novel Phage Infecting the Turkey Pathogen APEC O78 and Its Endolysin Activity.新型噬菌体感染土耳其病原体 APEC O78 的基因组分析及其溶菌素活性。
Viruses. 2021 May 31;13(6):1034. doi: 10.3390/v13061034.
4
The Advantages and Challenges of Using Endolysins in a Clinical Setting.在临床环境中使用内切溶素的优势和挑战。
Viruses. 2021 Apr 15;13(4):680. doi: 10.3390/v13040680.
5
The role of co-infections and secondary infections in patients with COVID-19.合并感染和继发感染在新冠肺炎患者中的作用。
Pneumonia (Nathan). 2021 Apr 25;13(1):5. doi: 10.1186/s41479-021-00083-w.
6
Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design.噬菌体编码的细菌细胞壁溶酶及其序列-功能关系在噬菌体衍生产品设计中的意义。
J Virol. 2021 Jun 24;95(14):e0032121. doi: 10.1128/JVI.00321-21.
7
Decontamination of Escherichia coli O157:H7 on fresh Romaine lettuce using a novel bacteriophage lysin.新型噬菌体溶菌酶对新鲜罗马生菜中大肠杆菌 O157:H7 的除菌作用。
Int J Food Microbiol. 2021 Mar 2;341:109068. doi: 10.1016/j.ijfoodmicro.2021.109068. Epub 2021 Jan 20.
8
Lysins breaking down the walls of Gram-negative bacteria, no longer a no-go.溶菌酶破坏革兰氏阴性菌的细胞壁，不再是不可行的。
Curr Opin Biotechnol. 2021 Apr;68:15-22. doi: 10.1016/j.copbio.2020.08.014. Epub 2020 Oct 11.
9
MMPphg from the thermophilic Meiothermus bacteriophage MMP17 as a potential antimicrobial agent against both Gram-negative and Gram-positive bacteria.热嗜甲基菌噬菌体 MMP17 来源的 MMPphg 作为一种潜在的抗革兰氏阴性和革兰氏阳性细菌的抗菌剂。
Virol J. 2020 Aug 25;17(1):130. doi: 10.1186/s12985-020-01403-0.
10
Phage Therapy in Poland - a Centennial Journey to the First Ethically Approved Treatment Facility in Europe.波兰的噬菌体疗法——通往欧洲首个获得伦理批准的治疗机构的百年征程。
Front Microbiol. 2020 Jun 5;11:1056. doi: 10.3389/fmicb.2020.01056. eCollection 2020.
Zotero 插件